Press Releases
October 7, 2015:
Quartet Medicine Completes $23.26 Million Series A Financing
June 15, 2015:
Quartet Medicine Announces Neuron Publication Validating Role of the BH4 Pathway in Chronic Neuropathic and Inflammatory Pain
May 19, 2015:
Quartet Medicine Announces Scientific Advisory Board Comprising Academic and Industry Neuroscience Leaders
October 23, 2014:
Quartet Medicine Launches with $17 Million Series A Financing
In the News
March 6, 2015:
Nature Biotechnology: Quartet Selected as a 2014 Top Academic Start-up
November 10, 2014:
BioCentury ECP: Quartet: Orchestrating Pain Relief
October 23, 2014:
Life Sci VC: Soothing Chronic Pain: Quartet’s Debut
Xconomy: New Atlas Startup Gets “Quartet” of Backers, $17M For Pain Drugs
FierceBiotech: Pfizer, Novartis Chip in on $17M Round for an Atlas Upstart Focused on Pain
Boston Globe: Quartet Medicine Raises $17M to Develop Treatments for Chronic Pain and Inflammation
Boston Business Journal: Atlas Venture’s Quartet Aims to Harness the Immune System to Make Painkillers
Reuters PE Hub: Quartet Medicine Scores $17M Series A